The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 20, 2020

Filed:

Sep. 11, 2017
Applicant:

Intrexon Actobiotics N.v., Zwijnaarde, BE;

Inventors:

Lothar Steidler, Lokeren, BE;

Klaas Vandenbroucke, De Pinte, BE;

Assignee:

INTREXON ACTOBIOTICS N.V., Zwijnaarde, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/74 (2015.01); C07K 14/575 (2006.01); C07K 14/435 (2006.01); A61K 39/00 (2006.01); A61P 3/10 (2006.01); C07K 14/335 (2006.01); A61K 35/741 (2015.01); C12N 9/88 (2006.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/335 (2013.01); A61K 35/74 (2013.01); A61K 35/741 (2013.01); A61P 3/10 (2018.01); C07K 14/435 (2013.01); C07K 14/575 (2013.01); C12N 9/88 (2013.01); A61K 39/00 (2013.01); A61K 2035/115 (2013.01); C07K 2319/00 (2013.01); C07K 2319/036 (2013.01);
Abstract

The present disclosure provides genetically modified microorganisms (e.g., bacteria or yeast) with enhanced mucin-binding and/or cell-adhesion properties. For example, the present disclosure provides bacteria exhibiting increased in vitro binding to Caco-2 cells, and increased in vitro binding to mucins. Such microorganisms (e.g., bacteria) can be used, e.g., to deliver bioactive polypeptides to the gastrointestinal tract of a mammalian subject. Modifying the microorganism in the described manner allows for the modulation of gastrointestinal retention and transit times for the microorganism (e.g., bacterium). Exemplary microorganisms (e.g., lactic acid bacteria, such as) contain an exogenous nucleic acid encoding a fusion protein containing a cell-adherence polypeptide, such as CmbA, and a mucin-binding polypeptide, such as a trefoil factor (TFF), e.g., human TFF3. The current disclosure further provides method for making and using the described microorganisms (e.g., bacteria).


Find Patent Forward Citations

Loading…